中国实用外科杂志

• 专题笔谈 • 上一篇    下一篇

腹腔热灌注化疗在胃癌腹腔转移治疗中的价值

吴晓江贾永宁季加孚   

  1. 北京大学肿瘤医院暨北京市肿瘤防治研究所胃肠肿瘤外科 恶性肿瘤发病机制及转化研究教育部重点实验室,北京100142
  • 出版日期:2015-10-01 发布日期:2015-10-09

  • Online:2015-10-01 Published:2015-10-09

摘要:

腹腔种植转移是胃癌的主要致死原因,一旦出现,预后极差。近年来,单纯的腹腔种植转移逐渐被认为是一种局部病变,可以采取更为积极的治疗方法,包括腹腔热灌注化疗、腹膜切除等。手术联合腹腔热灌注化疗可以大大降低术后腹腔复发率,腹膜切除联合腹腔热灌注化疗对胃癌合并明显腹腔种植转移也具有较好的治疗效果。选择潜在可获益的病人是获得良好疗效的重要前提。但是目前腹腔热灌注化疗仍然缺少一套标准的流程,还有待于进一步的前瞻性研究结果来使其标准统一。

关键词: 胃癌, 腹腔种植转移, 腹腔热灌注化疗, 肿瘤细胞减灭术

Abstract:

Hyperthermic intraperitoneal chemotherapy in the treatment of peritoneal carcinomatosis of gastric cancer            WU Xiao-jiang, JIA Yong-ning, JI Jia-fu. Department of Gastrointestinal Surgery, Peking University School of Oncology, Beijing Cancer Hospital & Institute; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Beijing 100142, China
Corresponding author: JI Jia-fu, E-mail:jiafuji@hotmail.com
Abstract    The peritoneal carcinomatosis is the main cause of death for gastric cancer. Once diagnosed, the prognosis is poor extremely. While simple peritoneal carcinomatosis has been considered as localized disease gradually, and more aggressive methods could be adopted including hyperthermic intraperitoneal chemotherapy (HIPEC) and peritoneal resection. Combination of surgery and HIPEC could significantly decrease the recurrence rate, and the combination of CRS and HIPEC could also enhance the therapeutic effect of gastric cancer patients with obvious peritoneal dissemination. Careful selection of the potential beneficiary is the key for better survival. But up to now a standard protocol is demanded highly, and more prospective clinical trials are needed to provide enough evidence for the protocol conformation.

Key words: gastric cancer, peritoneal carcinomatosis, hyperthermic intraperitoneal chemotherapy, cytoreductive surgery